Concepedia

Publication | Open Access

Safety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor−Positive Recurrent or Metastatic Endometrial Cancer

DOIFull Paper Access

73

Citations

28

References

2022

Year

Pierre-Étienne Heudel, Jean‐Sébastien Frenel, Cécile Dalban, Fernando Bazán, Florence Joly, Antoine Arnaud, Cyril Abdeddaim, Annick Chevalier-Place, Paule Augereau, Patricia Pautier,
JAMA Oncology

Abstract

ClinicalTrials.gov Identifier: NCT02730923.

References

YearCitations

Page 1